1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:. Baseline patient demographics
Total (n = 47 [%]) Patients with New Lesions in Treated Vascular Territory (n = 4 [%]) Patients without New Lesions in Treated Vascular Territory (n = 43 [%]) P
Age (years ± SD) 65.13 ± 7.08 61.75 ± 7.93 65.44 ± 7.02 0.324
Male/female 27/20 3/1 24/19 0.458
Symptomatic patients 
    TIA 18 (38.30) 3 (75) 15 (34.88) 0.149
    Stroke 17 (36.17) 0 (–) 17 (39.53) 0.281
Vascular risk factors 
    Diabetes 13 (27.66) 0 (–) 13 (30.23) 0.563
    Hypertension 32 (68.08) 4 (100) 28 (65.12) 0.290
    CHD 3 (6.38) 0 (–) 2 (4.65) 0.835
    Hyperlipidemia 12 (25.53) 1 (25) 11 (25.58) 0.738
    PAD 7 (14.89) 1 (25) 6 (13.95) 0.488
    Smoking^a 47 (100) 4 (100) 43 (100) –
Plaque characteristics 
    Fibrolipid 22 (46.81) 4 (100) 18 (41.86) 0.041
    Fibrocalcified 25 (53.19) 0 (–) 25 (58.13) 
Degree of stenosis (%) 
    Moderate (50–69) 2 (4.26) 0 (–) 2 (4.65) 0.835
    Severe (70–99) 45 (95.74) 4 (100) 41 (95.35) 
Aortic arch 
    Type 1 19 (40.25) 2 (50) 17 (39.53) 0.536
    Type 2 25 (53.19) 2 (50) 23 (53.49) 0.645
    Type 3 3 (6.38) 0 (–) 3 (6.98) 0.761
Type of stent 
    Wallstent 21 (44.68) 1 (25) 20 (46.51) 0.617
    Protégé 22 (46.81) 3 (75) 19 (44.19) 0.328
    Precise 4 (8.51) 0 (–) 4 (9.30) 0.116
Type of protection devices 
    AngioGuard 24 (51.06) 0 (–) 24 (55.81) 0.049
    Spider RX 20 (42.56) 3 (75) 2 (4.65) 0.002
    TwinOne 3 (6.38) 1 (25) 2 (4.65) 0.238

Note:—CHD indicates coronary heart disease; PAD, peripheral artery disease.


↵a. Smoking = past or present.